FGF23 and hyperphosphatemia: However, as CKD advances, overt hyperphosphatemia ensues; as aforementioned, adaptive effects of FGF-23, PTH, and 1,25(OH)2D to enhance phosphate excretion are not able to overcome the phosphorus retention from continued dietary phosphorus intake and progressive reduction in glomerular filtration rate (GFR).